HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wonjeong Cho Selected Research

N- (4- methyl- 3- (1- methyl- 7- (6- methylpyridin- 3- ylamino)- 2- oxo- 1,2- dihydropyrimido(4,5- d)pyrimidin- 3(4H)- yl)phenyl)- 3- (trifluoromethyl)benzamide

4/2021Novel and Potent Small Molecules against Melanoma Harboring BRAF Class I/II/III Mutants for Overcoming Drug Resistance.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Wonjeong Cho Research Topics

Disease

1Melanoma (Melanoma, Malignant)
04/2021

Drug/Important Bio-Agent (IBA)

1PLX8394IBA
04/2021
1N- (4- methyl- 3- (1- methyl- 7- (6- methylpyridin- 3- ylamino)- 2- oxo- 1,2- dihydropyrimido(4,5- d)pyrimidin- 3(4H)- yl)phenyl)- 3- (trifluoromethyl)benzamideIBA
04/2021
1VemurafenibIBA
04/2021
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
04/2021